Alnylam Pharmaceuticals’s Vice President, Drug Discovery and Development Honored with American Chemical Society Award

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that Dr. Muthiah Manoharan, Vice President, Drug Discovery and Development, has been honored with the Melville L. Wolfrom Award of the Division of Carbohydrate Chemistry of the American Chemical Society.

MORE ON THIS TOPIC